MedTrace Logo

Study to Evaluate the Interaction Between Aspirin and Nexium

NCT01199328 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2010-11-19

No results posted yet for this study

Summary

The purpose of this study is to assess the interaction between aspirin and Nexium in healthy volunteers.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Aspirin

81mg Tablet oral, once daily

DRUG

Esomeprazole

20 mg Tablet oral, once daily

Sponsors & Collaborators

Principal Investigators

  • Dennis N Morrison, MD · Bio-Kinetic Clinical Applications

  • Tore Lind · AstraZeneca

  • Lynne Durborow · AstraZeneca

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01199328 on ClinicalTrials.gov